Filing Details
Xtant Medical Holdings, Inc. (AMEX:XTNT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
The Healthcare company reported Q0 revenue of .
10q filedAMEX:XTNT
Xtant Medical Holdings, Inc. (XTNT) Files Quarterly Report for Q0
Xtant Medical Holdings, Inc. (AMEX:XTNT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
At publication ·
What changed
Xtant Medical Holdings, Inc. (AMEX:XTNT) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Xtant Medical Holdings, Inc. filed its quarterly report (Form 10-Q) with the SEC on August 11, 2026, providing unaudited financial statements and management commentary for Q0.
- The company's stock trades at $0.32 per share with a market capitalization of $97.8 million.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions, though the article does not specify Q0 revenue figures or other financial metrics.
Market Context
Xtant Medical Holdings, Inc.'s stock currently trades at $0.32 with a market capitalization of $97.8M.
The 10-Q provides Xtant Medical Holdings, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Xtant Medical Holdings, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View XTNT Stock Page
Frequently Asked Questions
Where can I read XTNT's SEC filings?
Browse all filings on our XTNT SEC filings page.
What types of SEC filings does Xtant Medical Holdings, Inc. file?
Public companies like Xtant Medical Holdings, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.